The S107 IgA K-chain myeloma cell line makes an antiphosphocholine antibody of the T15 idiotype. A somatic mutant of this line, U4, makes an immunoglobulin with 'a single amino acid substitution of an alanine for a glutamic acid at residue 35. This single amino acid change results in a loss of phosphocholine binding activity. However, the U4 immunoglobulin has acquired reactivity with a variety of phosphorylated macromolecules, including double-stranded DNA, protamine, and cardiolipin. Thus, a single amino acid change in the T15 heavy chain can transform an antibacterial antibody into an antibody that resembles the autoantibodies seen in mice and man with autoimmune disease.
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It has now been established that the enormous sequence diversity of antibodies is generated through the availability of multiple germ line variable (V) region genes, their successive rearrangement to a limited number of diversity (D) and joining (J) mini genes, the junctional diversity that occurs during these rearrangements, and subsequent somatic mutation of the already rearranged genes (1) . Although it is clear that somatic mutations play a major role in generating antibody diversity (1, 2) , it has not been determined whether this is a random process, generating antibodies with increases and decreases in affinity for the eliciting antigen. If antibodies that have lost the ability to bind antigen do emerge, it is not known whether they acquire reactivity for other antigens or are just wastage.
Somatic mutation may be particularly relevant to the origins and regulation of expression of autoantibodies. Workers concerned with this question have suggested that at least some autoantibodies may arise by the somatic mutation of germ line genes that originally encode antibodies that recognize foreign antigens (3) . Although autoantibodies recognize self components, it is not clear that the self components are the immunogens that initiate the production of autoantibodies (4) . In fact, in strains of mice that make anti-doublestranded DNA (ds DNA) antibodies and develop autoimmune disease, ds DNA is a poor immunogen and those antibodies elicited by ds DNA differ in their specificity from the spontaneously arising autoantibodies (4) . These and related considerations have led to the suggestion that infectious agents, and especially bacteria, may originally stimulate the production of self-reactive antibodies (4, 5) .
Eilat et al. (6) have recently sequenced the heavy chain of a monoclonal antibody from an NZB/NZW F1 mouse that binds ds DNA and found that the sequence of its heavy chain V region closely resembles that of an antiphosphocholine (PCho) antibody from a CBA/J mouse (7) , except that it has a serine instead of a glutamic acid at residue 35 (6) . These authors suggested that the anti-DNA antibody from the NZB/NZW mouse may have been derived by somatic mutation from the V11 germ line gene of the T15 heavy chain V region gene family (6) . The prototype antibodies of this family are T15 and S107 (8) , which bind P-Cho, and are the predominant (9) and protective (10) antibodies that anise in BALB/c mice in response to immunization with rough pneumococci and other bacteria.
This observation prompted us to examine the reactivity of antibodies we had derived by somatic mutation in tissue culture from the S107 myeloma cell line (2) . S107 produces an IgA K-chain P-Cho binding antibody that is identical in its sequence to the T15 (V1) germ line heavy chain V region sequences (8) . We have identified a somatic mutant of S107, U4, which produced an antibody that had lost the ability to bind P-Cho (11) . This loss of reactivity was associated with a single amino acid substitution of an alanine for a glutamic acid at residue 35 of the first heavy chain hyper-V region (11) .
We here report that U4 reacts with ds DNA, phosphorylated protamine, and cardiolipin. This finding indicates that a germ line V region gene coding for an antibacterial antibody can, as the result of somatic mutation in the heavy chain V region, code for an antibody that has lost the ability to bind the bacterial antigen and acquired binding for self components. It also suggests that somatic mutations resulting in the loss of binding to the eliciting antigens may lead to binding to other antigens and thus increase the repertoire of antibodies. METHODS Cell Lines. The S107.3.4 (S107) cell line has been described (12) . It secretes an IgA K-chain antibody of the T15 idiotype (13) . The M511 (511) and McPC 603 (603) cell lines were generated by fusing cells from the respective tumors with the X63.Ag8.653 cell line as has been described (14) .
The 511 and 603 proteins are IgA K-chain proteins that bind P-Cho (13). U4 and U10 are somatic variants of the S107 cell line that differ from the parent by single amino acid substitutions in the heavy chain (11, 15 100 ,ul of a 1:100 dilution of mouse serum. The reaction mixtUre was passed through a Millipore filter that was assayed for 32P-labeled DNA.
Mice. BALB/c mice were obtained from The Jackson Laboratory. They were bled at 10-12 wk. Serum was diluted in Tris/NaCl/1% bovine serum albumin.
MRL/lpr mice were originally obtained from The Jackson Laboratory but have since been bred in our own animal institute. Mice were bled at 10-12 wk and their serum was diluted in Tris/NaCl/1% bovine serum albumin.
RESULTS
The S107 IgA K-chain P-Cho binding antibody expresses the germ line sequence of the T15 heavy and light chain V region genes (8, 20, 21) . The heavy chain V region of the S107.3.4 tissue culture cell line has the same amino acid sequence as that reported for the protein produced by the original tumor (11) and binds P-Cho with the same affinity of -2.5 x 10-' MW1 (11) . The U4 subclone is a somatic mutant of S107.3.4 that does not bind P-Cho-KLH (11, 12) . There was no detectable binding of P-Cho by equilibrium dialysis and U4 did not compete with S107 for binding to P-Cho-KLH even when high concentrations were used. However, if P-Cho-KLH or P-Cho-bovine serum albumin was attached to plastic wells, some U4 binding could be detected by this sensitive direct binding assay (15) .
U4 assembles into H2L2 molecules that are then polymerized into higher IgA polymers that are indistinguishable from those produced by the parental cell. Chain recombination (11) . The amino acid substitution is the result of a single A-C transversion in the codon that codes for residue 35 and no other base changes have been detected (15) . Not only does U4 react very poorly with P-Cho but it is also no longer recognized by some (but not all) monoclonal anti-idiotypic (T15) antibodies. Thus, it could be considered a degenerate product of the T15 heavy chain gene that would not normally be identified in vivo both because of its loss of antigen binding and loss of idiotypic determinants. Since, as noted above, an anti-DNA antibody from an NZB/NZW F1 mouse has a heavy chain that could have been derived from a closely related T15 germ line gene (6), we examined the ability of U4 antibody to bind to ds DNA. As can be seen in Table 1 , in a direct binding assay, S107 antibody binds well to P-Cho-KLH and hardly at all to ds DNA adsorbed to protarmine. On the other hand, U4 binds slightly to P-Cho-KLH and significantly to DNA-protamine.
The results of the assay described in Table 1 suggested U4 might resemble autoantibodies seen in MRL/lpr and NZB/NZW autoimmune mice (22) and in patients with systemic lupus (23, 24) ; thus, further studies were done to define the specificity of the S107 and U4 antibodies. Two other IgA K-chain myeloma proteins, M511 and McPC 603, which are also somatic variants derived from the T15 heavy chain V region gene, were also examined (8) . Both 511 and 603 differ from T15 in their D regions and 603 also contains two amino acid substitutions in its heavy chain V region (8) . In addition, 511 and 603 have light chains that are different and bear little homology to the T15 light chain (13, 21) . Both 603 and 511 bind P-Cho with a lower affinity than S107 but are difficult to distinguish from S107 in direct binding assays ( Table 2) . As controls, another somatic mutant of S107, U10, which does not bind P-Cho at all (15) , and medium that had not been incubated with cells were used. For comparison, serum from BALB/c and 10-to 12-wk-old MRL mice were used. At this age there are easily detectable anti-ds DNA binding antibodies in MRL mice (22) . Sera from a number of MRL mice were tested and the one shown here is representative, although occasional sera had higher or lower binding.
It has been reported that some antibodies detected in the DNA-protamine assay bind protamine rather than DNA (25). Since we wished to know whether U4 was binding to ds DNA, protamine, or both, binding to these two was measured separately. Protamine binding was again assayed by a direct binding radioimmunoassay on polystyrene plates (17) . The ds DNA binding was assayed by a filter binding assay in which radioactive DNA is incubated with medium containing the antibody. DNA binding is measured by the amount of DNA-antibody complex retained on the filter (19) . In our hands, this is a more reliable way to measure binding to ds Proc. NatL Acad Sci. USA 81 (1984) DNA than the plate assay. As can be seen in Table 2 , S107, 511, and 603 all bind P-Cho-KLH well and U4 binds much less well. U4 binds well to ds DNA, whereas the bidding of S107, 511, and 603 is higher than that of U10 or medium but similar to BALB/c serum diluted 1:100. MRL serum binds well to both ds DNA and P-Cho. It is difficult to quantitatively relate the binding of MRL serUm to that of homogeneous antibodies. In competition experiments, U4 can inhibit the binding of most of the MRL antibodies to protamine-DNA, but, since the MRL serum contains a mixture of classes and subclasses (26) and of various specificities in unknown quantities, we are uncertain how to interpret this finding.
Since both sera and monoclonal antibodies from autoimmune mice also bind to protamine and cardiolipin, presumably because of the presence of phosphate groups in ds DNA, protamine, and phospholipids (25, 27) , we examined the ability of S107 and U4 to bind to these molecules (Table   2 ). U4 bound better than S107, 511, 603, or U10 to these antigens. This indicated that U4 has a crossreactivity pattern that is roughly similar to those reported for anti-ds DNA antibodies in man and mice with lupus-like syndromes (23) (24) (25) 27) .
In order to be certain that U4 was recognizing specific structures on DNA and protamine, the binding of U4 and S107 to other basic proteins was examined. Neither bound more than a medium control to poly(lysine) br poly(arginine) ( Table 3) . Furthermore, neither bound appreciably to unphosphorylated rainbow trout sperm protamine. When the protamine was phosphorylated, S107 still did not bind well, Rainbow trout protamine that is not phosphorylated or phosphorylated rainbow trout protamine (P-protamine), poly(lysine), or poly(arginine) was adsorbed to polystyrene wells. Medium containing either S107 or U4 at an equivalent concentration was added for 1 hr followed by radiolabeled anti-K chain. Values represent the average of cpm of two wells, each of which differed from the mean by <10%. Binding to nonphosphorylated protamine with ATP was indistinguishable from binding to nonphosphorylated protamine alone. Background radioactivities of 314 cpm for phosphorylated protamine, 320 cpm for nonphosphorylated protamine, 192 cpm for poly(lysine), and 157 cpm for poly(arginine) were subtracted.
whereas U4 bound at two times over background. Although we have not quantitated the degree of phosphorylation, we conclude that because phosphorylation can cause U4 to bind to protamine, U4, like spontaneously arising anti-DNA antibodies (23) (24) (25) 27) , recognizes a phosphate determinant.
DISCUSSION
Recent studies of panels of monoclonal antibodies derived from single germ line genes have confirmed that base changes occur frequently in heavy and light chain V regions after they have been rearranged and expressed ( 1, 2, 21, 28 ).
It is not clear whether the genetic instability of V region genes is due to hypermutation (21, 28, 29) , gene conversion (30, 31) , or some yet to be defined mechanism. However, it has been estimated that base changes occur in V region genes at rates as high as i0o3 per base pair per generation (32) .
Some of the monoclonal antibodies that differ from the germ line sequence have higher affinities than the antibodies encoded by the unmutated germ line gene (33, 34) . This suggests that there is selection in the animal for antibody-forming B cells producing higher affinity antibodies. However, if the genetic events are random, they must also produce antibodies that are lost to routine analysis because of their lower affinity for the immunizing antigen. If such antibodies are generated frequently in vivo, we do not know if they react with other common environmental antigens and are therefore preserved in the repertoire.
Because many of the questions about somatic mutation are difficult to answer in vivo, where selection and regulation of expression are occurring, we have been examining the genetic instability of heavy chain V region genes in cultured myeloma cells (2) . This somatic cell genetic system seemed particularly suited for determining the rate at which base changes occur and whether somatic mutation also generates antibodies that have lost the ability to react with the immunizing antigen. We have worked with cells producing the S107 IgA K-chain P-Cho binding antibody because (i) this is the predominant antibody made by BALB/c mice in response to many bacteria, including rough pneumococci (9) , and it is protective (10) ; (ii) like the prototype T15 antibody, it is identical in sequence with the T15 germ line heavy and light chain V region sequences (8, 20, 21) ; (iii) the family of T15 (S107) heavy chain V region genes has been sequenced (8) ; and (iv) the three-dimensional structure of a closely related antibody has been determined (35) . In the course of these studies we identified a somatic mutant of S107, U4, which produced an antibody that had lost the ability to bind P-Cho (11) .
We have shown previously that in the U4 somatic mutant a single amino acid substitution of alanine for glutamic acid at residue 35 in the heavy chain V region results in a large decrease in P-Cho binding (11) . Since the heavy chain contains three contact residues and the light chain contains one for P-Cho (36), it was surprising that the single substitution of an alanine for glutamic acid had such a dramatic effect on P-Cho binding. However, the three-dimensional structure of the related 603 binding site reveals that the glutamic acid at residue 35 of the heavy chain forms a hydrogen bond with tyrosine at residue 94 of the light chain (36) . This had led to the suggestion that residue 35 is important in determining the conformation of the P-Cho binding site (36) . This is confirmed by the presence of glutamic acid at residue 35 in virtually all P-Cho binding antibodies (21, 37) .
The U4 heavy chain V region differs from the germ line by a single A-C transversion in the codon for glutamic acid at residue 35 and has presumably arisen from the germ line gene by somatic mutation (15) . Our results show that the U4 mutant, as a result of a single base change in a germ line gene, loses the ability to react effectively with P-Cho and acquires the ability to react with ds DNA and other phosphorylated macromolecules. It is important to note that the antigenic specificity of U4 is similar to that of autoantibodies found in the serum of diseased mice-i.e., it reacts with ds DNA, with phosphorylated protamine, and, to some extent, with cardiolipin. It has been suggested that choline in P-Cho resides in the region of the binding site adjoining residue 35, whereas other parts of this site bind to the phosphate group (35) . This is consistent with the findings reported here.
These studies confirm the suggestion of Eilat 
